Wells Fargo analyst Mohit Bansal has maintained their bullish stance on VRTX stock, giving a Buy rating yesterday. Mohit Bansal has given his ...

Vertex Pharmaceuticals (VRTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Vertex Pharmaceuticals dominates the cystic fibrosis market with a promising pipeline and strategic M&A activity. Read why I ...

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts ...

It was reported on October 15, that ITEM SECOND IRR TRUST FBO ANNE MARIE WESTPHAL ua of JEFFREY R WESTPHAL dated October , 10% Owner at Vertex VERX executed a significant insider sell, according to an ...

BOSTON, October 18, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on suzetrigine, an investigational, oral ...

After hours: October 18 at 7:57 PM EDT Loading Chart for VRTX ...

Regeneron Pharmaceutical (NASDAQ:REGN) fell 2% after a court rejected its request for a temporary injunction blocking sales ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...